Russia is at the forefront of the vaccine of COVID-19, has Russia successfully tested the vaccine?
Hello Friends, Recently, as you might know, COVID-19 has proved to be an epidemic. In the case of its vaccine, many trials are currently underway, each country claims to have become a vaccine. But Russia is at the forefront of this and is successful in testing it first. Russia achieved success in it. India is also working with the country. It has been approved for trial in 12 hospitals.
Russia claims to have a successful vaccine:
On July 12, cyberspace was flooded with reports that Russian researchers had successfully completed testing for the world’s first coronavirus vaccine. The Russian newspaper agency, TASS, had reported that a “clinical trial” of a vaccine conducted by scientists at Sechanov First Moscow State Medical University was held, in which the drug was tested on two groups of volunteers. Out of which 15 were to be discharged. And on July 20, the second trial will be started.
Has Russia made a successful vaccine? If yes, then this medicine can also be wrong:
If indeed, Moscow Varsity had achieved such success, then to say that it would come as a sigh of relief for the rest of the world would be a great experience. The entire planet has been in the grip of an epidemic for six months, with Russia, the fourth-worst affected nation. However, upon closer inspection, it appears that reports of Russian university researchers developing a commercially viable vaccine may be incorrect.
What is Status of India?
Given this, a recent letter from the government tried to speed up clinical trials for a vaccine candidate, which it is developing in collaboration with the Hyderabad-based pharmaceutical company to develop the world’s first COVID-19 vaccine is at the final stage. But in a historically unique global race for a vaccine, India is still at some distance.
Two Indian vaccine candidates have approved this phase and received regulatory approval to move to the next stage – clinical trials – although the WHO document does not list covaxin. The vaccine candidates were pushing the Indian government and asked why this happened? The WHO representative emailed that WHO had “a list of attributes and criteria that WHO would evaluate as COVID-19 candidates to be considered for further development and Provide ideas for priority.” But did not state what criteria covaxin does not meet.
AIIMS Patna is one of the 12 institutes selected by the Indian Council of Medical Research (ICMR) to conduct coronavirus vaccine trials.
According to the guidelines issued by the ICMR for human trials:
* The first dose of vaccine will be given only to those who report well.
* Patients will be given a total of three doses of the injection to complete the trial process.
After the first dose of the vaccine, the patient will be under a doctor’s supervision for 2 to 3 hours, after which they will be sent home.